==== Front Cureus Cureus 2168-8184 Cureus 2168-8184 Cureus Palo Alto (CA) 10.7759/cureus.39873 Cardiology Internal Medicine Sudden Cardiac Death in Athletes: Consensuses and Controversies Muacevic Alexander Adler John R Ghani Usman 1 Farooq Omer 2 Alam Sundus 3 Khan Muhammad Junaid 4 Rahim Omar 5 Rahim Sarah 6 1 Cardiology, Northwest General Hospital and Research Center, Peshawar, PAK 2 Internal Medicine, Presence Saint Francis Hospital, Evanston, USA 3 Cardiology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, GBR 4 Orthopaedic Surgery, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, GBR 5 Internal Medicine, Naseer Teaching Hospital, Peshawar, PAK 6 Cardiology, Rehman Medical Institute, Peshawar, PAK Usman Ghani ghaniusman13@yahoo.com 2 6 2023 6 2023 15 6 e398732 6 2023 Copyright © 2023, Ghani et al. 2023 Ghani et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This article is available from https://www.cureus.com/articles/160294-sudden-cardiac-death-in-athletes-consensuses-and-controversies Exercise is widely considered beneficial for cardiovascular health. However, on rare occasions, athletes experience sudden cardiac death without any preceding symptoms. The devastating nature of these events necessitates us to understand the underlying causes. In younger athletes (age <35), the underlying causes are usually hereditary/genetic, whereas in older athletes (age >35), coronary artery disease is prevalent. Sudden cardiac death in athletes can occur regardless of the presence of any structural abnormality in the heart. Despite divergence between guidelines, the majority of cardiology societies recommend at least taking a comprehensive history and performing physical examinations for initial screening for all athletes. This article reviews the consensuses and controversies regarding the incidence, causes, and prevention of sudden cardiac death in athletes.  mechanism prevention cause incidence athlete's heart athlete sudden cardiac death (scd) ==== Body pmcIntroduction and background Generally, sudden cardiac death in athletes is death occurring from cardiac arrest within an hour of acute change in clinical status if the event was witnessed, or an unexpected death within 24 hours if the episode was not witnessed. The reported incidence of sudden cardiac death in athletes has been highly variable across studies. We explore the methodical variations across studies that have led to these inconsistencies. Moreover, the consensus on certain groups of athletes who are relatively at a higher risk is also discussed. Sudden cardiac death usually presents in athletes without any previously known cardiac conditions who are otherwise asymptomatic. The demanding nature of competitive sports can precipitate a cardiac arrest in the presence of an underlying cardiac pathology. These catastrophic events are usually the first presentation of the underlying condition. Screening for these conditions can prevent sudden cardiac death but there is an ongoing debate as to which modalities should be included and whether widespread screening should even be reinforced as athletes may be disqualified from participating in the sport [1]. Sudden cardiac death in athletes is caused by both genetic/congenital and acquired cardiac conditions. Both groups of athletes (with structurally normal or abnormal hearts) are at risk. These athletes are usually asymptomatic until the event. Sometimes (in athletes with structurally normal hearts) the underlying condition is not identified even on autopsy. Sudden cardiac death in older athletes (age >35) is usually due to underlying coronary artery disease, however, in younger athletes (age <35), ion channelopathies and primary cardiomyopathies are usually the underlying causes [2]. Continual research is needed to understand the underlying causes of sudden cardiac death in athletes, with the ultimate goal of devising preventive strategies to reduce the incidence in the population. Methods A review of the literature was done from electronic databases (Pubmed, Scopus, and Google Scholar) to identify relevant peer-reviewed articles. Publications from 1959 to 2023 were included. The following search terms were used, “sudden cardiac death’’ and “athlete”. Articles in the English language were included. The inclusion criteria were not exclusive to any specific study design. For this study, 283 relevant articles were included and 50 were referenced. Findings were presented using a narrative approach. The data were summarised to highlight consensuses and controversies regarding the incidence, causes, and prevention of sudden cardiac death in athletes. Review Differentiating pathologic cardiac conditions from athlete's heart Preventing sudden cardiac death in athletes includes careful identification of the underlying cardiac pathologies. Therefore, it is imperative to understand the differences between normal physiologic and pathologic changes in the heart [3,4]. Table 1 delineates the physiologic changes that occur in athlete’s heart. Table 1 Physiologic changes in athlete's heart AV- Atrioventricular; LVH- left ventricular hypertrophy; RVH- right ventricular hypertrophy; RBBB- right bundle branch block Electrical changes Structural changes Functional changes Sinus bradycardia Increased left and right ventricle cavity Increased diastolic filling Sinus arrhythmia Increased left ventricular wall thickness Increased augmentation of stroke volume First degree AV block Biatrial enlargement   Voltage criteria LVH and RVH     Incomplete RBBB     Cardiac adaptations can vary depending on the type of exercise athletes perform. Table 2 differentiates between the cardiac changes that occur in athletes based on the type of training they undergo while also indicating the similarities. Table 2 Physiologic changes due to different types of activities LV- left ventricle; LA- left atrium; LVWT- left ventricular wall thickness; RV- right ventricle Resistance Training Aerobics Concentric LV hypertrophy Eccentric LV hypertrophy   Mild LA hypertrophy. Increased LVWT and minimal change in LV volume LV dilation and proportional LVWT Mild LA hypertrophy Mild RV dilation   Activation of progenitor cells Biatrial enlargement   Reversible Cardiomyocyte proliferation     Activation of progenitor cells     Reversible Cardiac physiologic adaptations are usually mild/moderate and are reversible, however, pathologic changes are usually severe and irreversible. The major differences in physiologic and pathologic changes in the heart are mentioned in Table 3. Table 3 Common differences in cardiac physiologic and pathologic hypertrophy SCD- sudden cardiac death; HF- heart failure Physiologic hypertrophy Pathologic hypertrophy Reversible Irreversible Low incidence of SCD and HF   High incidence of SCD and HF   Regression with detraining Does not regress Mild/moderate structural changes Frank structural changes Normal cardiac function Reduced cardiac function Incidence of sudden cardiac death in athletes There is huge variability in the reported incidence of sudden cardiac death in athletes across numerous studies. Steinvil et al. [5] reported an incidence of 1/39000 (per athlete-person years), whereas, Van Camp et al. [6] reported an incidence of 1/281,000 (per athlete-person years). Due to the lack of a unifying definition of an athlete, the definition of sudden cardiac death in an athlete varies, which leads to heterogeneous grouping across studies and selection bias. Some studies include exclusively sudden cardiac deaths [7-10], while others have broader inclusive criteria that include sudden cardiac deaths and sudden cardiac arrests (reverted with the return of spontaneous circulation) [11,12]. Moreover, there is a lack of similar enforcement of screening and provision of automated external defibrillators in different countries which leads to inconsistent findings across studies carried out in different geographic locations [2]. The lack of a thorough post-mortem evaluation by cardiac pathologists or even a thorough evaluation in patients with structurally normal hearts may also lead to inaccurate diagnosis of the cause of death. There appears to be a general consensus that the risk of sudden cardiac death in athletes increases with age [13-16]. The incidence of sudden cardiac death in athletes is greater in certain groups, namely, male [10,15,17-23], african american players [10,17-19], and basketball players [17,19,24]. However, studies carried out in Spain [25] and Italy [21] reported a relatively higher incidence among soccer players. This may be due to the fact that more athletes in Europe play soccer. Causes of sudden cardiac death in athletes Sudden cardiac death in athletes is caused by a variety of conditions. In older athletes (age >35), the most common cause is usually reported to be coronary artery disease [26]. It is still up for debate whether the sudden cardiac death is due to plaque rupture or due to the imbalance in supply and demand [19]. In younger athletes (age <35), the most common pathway for sudden cardiac death is an arrhythmia which may be precipitated by different underlying pathologies. Hypertrophic cardiomyopathy is often reported as the most common underlying cause in this age group [26], however, studies in Italy [27] and Denmark [28] have reported the most common underlying cause to be arrhythmogenic right ventricular cardiomyopathy. An analysis of 1866 cases reported congenital coronary artery anomalies to be the second most common cause [29]. The various causes of sudden cardiac death in athletes are presented in Table 4. Table 4 Common cardiac conditions causing sudden cardiac death in athletes ARVC- Arrhythmogenic right ventricular cardiomyopathy; WPW- Wolff-Parkinson-White; CPVT- Catecholaminergic polymorphic ventricular tachycardia Structurally Abnormal Heart Structurally Normal Heart Hypertrophic cardiomyopathy Substance ingestion Dilated cardiomyopathy WPW syndrome Coronary artery disease (athletes >35 years old) Commotio Cordis ARVC Brugada syndrome Valvular heart disease Long QT syndrome Congenital abnormalities of the coronary arteries Electrolyte abnormalities Marfan syndrome   CPVT Myocarditis Environmental factors Left ventricular non-compaction cardiomyopathy Substance ingestion Kawasaki disease   Mechanisms of sudden cardiac death in athletes The aforementioned causes lead to sudden cardiac death in athletes through the following mechanisms. Coronary Artery Disease Coronary artery disease causes sudden cardiac death [26] either due to plaque rupture or due to the incapacity of the myocardium to adapt to increased requirements of the body during exertion [19]. Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Electrolyte Abnormalities, Long QT Syndrome, Brugada Syndrome, and Myocarditis Hypertrophic cardiomyopathy [30], dilated cardiomyopathy [31], electrolyte abnormalities [32], myocarditis [30], long QT syndrome (a common cause of sudden cardiac death in swimmers) [33], Brugada syndrome [34], and arrhythmogenic right ventricular cardiomyopathy [28,30] can precipitate ventricular tachycardia/ventricular fibrillation, ultimately leading to sudden cardiac death. Coronary Artery Anomalies The different types of coronary artery anomalies can lead to myocardial ischemia and sudden cardiac death in the setting of increased physical activity [30,34]. Catecholaminergic Polymorphic Ventricular Tachycardia Catecholaminergic polymorphic ventricular tachycardia, as evidenced by the name, causes ventricular tachycardia (premature ventricular beats) [30]. Left Ventricular Non-compaction Cardiomyopathy Left ventricular non-compaction cardiomyopathy causes heart failure and ventricular arrhythmia [35]. Wolff-Parkinson-White Syndrome Wolff-Parkinson-White syndrome causes sudden cardiac death usually through an arrhythmia (atrial fibrillation/ventricular fibrillation) [36]. Valvular Heart Disease Valvular heart disease leads to an imbalance in supply and demand either due to stenosis or insufficiency [37]. Marfan Syndrome Marfan syndrome causes sudden cardiac death through aortic root dissection or rupture [34]. Kawasaki Disease Coronary artery aneurysms in patients with Kawasaki disease can cause stenosis and occlusion of the coronary artery due to aneurysm remodeling, thereby causing myocardial ischemia [38]. Commotio Cordis Commotio cordis causes ventricular fibrillation and cardiac arrest in normal hearts (precipitated by trauma) [34]. Performance-Enhancing Substances Performance-enhancing substances can cause sudden cardiac death through different mechanisms depending on the specific substance being taken. Energy drinks/caffeine cause increased demand and reduced supply thereby causing myocardial ischemia leading to ventricular arrhythmia [39]. Anabolic steroids cause hypertension, dyslipidemia, myocyte hypertrophy, interstitial fibrosis, cardiac remodeling, and exercise-induced cardiac injury. There have been proposed four different mechanisms leading to sudden cardiac death in anabolic steroid users (atherogenic, thrombosis, vasospasm, or direct myocardial injury) [40]. Erythropoietin increases the risk of thrombosis [41] and growth hormones cause cardiac remodeling [42]. Hypothermia and Heatstroke Hypothermia reduces pacemaker automaticity and disturbs ion channel activity eventually leading to reduced cardiac output, it also causes coronary ischemia and arrhythmias (tachycardia and atrial fibrillation). Heatstroke causes heart failure and fatal cardiac arrest. Preventive strategies Prevention of sudden cardiac death in athletes can be achieved through pre-participation screening, training in performing cardiopulmonary resuscitation, provision of automated external defibrillators, and team education. Pre-participation Screening There is no general consensus on what should be included in the screening and whether screening should even be implemented. American Heart Association, American College of Cardiology and European Society of Cardiology recommend taking a detailed history along with performing a physical examination [43-47], however, American Heart Association does not recommend electrocardiography, whereas, the European Society of Cardiology recommends it as an additional screening tool [44-46]. Some factors that encourage the decision to not recommend electrocardiography are false negative and false positive results, uncertain benefits, and cost-related issues. Disqualification of the athlete from the sport is a concern that leads to recommendations against screening altogether [1]. Any concerning findings on the above-mentioned evaluations should be followed by further relevant investigations like echocardiography, cardiac stress test, 24-hour Holter monitoring, and cardiac magnetic resonance imaging [48]. Cardiopulmonary Resuscitation and Automated External Defibrillators Cardiopulmonary resuscitation and automated external defibrillators can be lifesaving in the setting of an unprecedented cardiac arrest. Certain cases of sudden cardiac death in athletes occur in a normal heart (due to commotio cordis), which cannot be prevented by screening and must be resuscitated with cardiopulmonary resuscitation and automated external defibrillators. Team Education As mentioned in Table 4, substance ingestion can cause sudden cardiac death, therefore, it is crucial to encourage athletes to discuss with a doctor the risks and benefits of any performance-enhancing substances they might be taking. Athletes should also be careful to avoid hypothermia and heat stroke. Any symptoms like chest pain, palpitations, and shortness of breath warrant an evaluation by a doctor. Previously, younger athletes with channelopathies were advised to refrain from sports entirely, but with our current understanding of the mechanisms, improved anti-arrhythmic medications, and larger available data, American Heart Association and American College of Cardiology guidelines are more lenient, thereby allowing certain patients with long QT syndrome to participate in sports provided they get regular checkups and take appropriate medications [49,50]. Conclusions In light of the high variability of reported incidence of sudden cardiac death in athletes, we recommend further studies be done. Any concerning symptoms (chest pain, shortness of breath, palpitations) experienced by athletes warrant an evaluation by a doctor. Pre-participation screening should be a shared decision due to concerns regarding false positive/false negative results, cost-effectiveness, and psychological impact on athletes who may be disqualified from the sport. Pre-participation screening should include a detailed history, followed by a thorough physical examination (electrocardiography is also advisable based on European guidelines). Any concerning findings on pre-participation screening warrant further relevant investigations (echocardiography, cardiac stress test, 24-hour Holter monitoring, and cardiac magnetic resonance imaging). Moreover, it would be sensible to keep a lower threshold for pre-participation screening in certain groups of athletes who are relatively at a higher risk of sudden cardiac death (age >35, men, African American athletes, basketball players, and soccer players in Europe). As sudden cardiac death in athletes cannot always be prevented even through the implementation of widespread screening, educating athletes about cardiac symptoms, the effects of substance ingestion, and lifestyle modifications are imperative. Lastly, training in cardiopulmonary resuscitation and the provision of automated external defibrillators can significantly reduce the incidence. The authors have declared that no competing interests exist. ==== Refs References 1 Time out: ethical reflections on medical disqualification of athletes in the context of mandated pre-participation cardiac screening Br J Sports Med Magavern EF Finocchiaro G Sharma S Papadakis M Borry P 1207 1210 52 2018 https://bjsm.bmj.com/content/52/18/1207.abstract 29021245 2 Sudden cardiac death in athletes: facts and fallacies J Cardiovasc Dev Dis Han J Lalario A Merro E Sinagra G Sharma S Papadakis M Finocchiaro G 68 10 2023 https://www.mdpi.com/2308-3425/10/2/68 36826564 3 International recommendations for electrocardiographic interpretation in athletes Eur Heart J Sharma S Drezner JA Baggish A 1466 1480 39 2018 https://pubmed.ncbi.nlm.nih.gov/28329355/ 28329355 4 How to interpret right ventricular remodeling in athletes Clin Cardiol Sanz-de la Garza M Carro A Caselli S 843 851 43 2020 https://pubmed.ncbi.nlm.nih.gov/32128858/ 32128858 5 Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol Steinvil A Chundadze T Zeltser D 1291 1296 57 2011 https://reader.elsevier.com/reader/sd/pii/S0735109711000064?token=E50D4EC19701EB72E842D1CAF40523D41A5597AAAF630052AE78E12D40ADC3E6453989439E9498F19F89C24BF27BAE85&originRegion=eu-west-1&originCreation=20230514044523 21392644 6 Nontraumatic sports death in high school and college athletes Med Sci Sports Exerc Van Camp SP Bloor CM Mueller FO Cantu RC Olson HG 641 647 27 1995 https://europepmc.org/article/med/7674867 7674867 7 Use of automated external defibrillators at NCAA Division I universities Med Sci Sports Exerc Drezner JA Rogers KJ Zimmer RR Sennett BJ 1487 1492 37 2005 https://pubmed.ncbi.nlm.nih.gov/16177599/ 16177599 8 Incidence of sudden cardiac death in National Collegiate Athletic Association athletes Circulation Harmon KG Asif IM Klossner D Drezner JA 1594 1600 123 2011 https://pubmed.ncbi.nlm.nih.gov/21464047/ 21464047 9 Incidence and causes of sudden death in U.S. college athletes J Am Coll Cardiol Maron BJ Haas TS Murphy CJ Ahluwalia A Rutten-Ramos S 1636 1643 63 2014 https://pubmed.ncbi.nlm.nih.gov/24583295/ 24583295 10 Incidence, etiology, and comparative frequency of sudden cardiac death in NCAA athletes: a decade in review Circulation Harmon KG Asif IM Maleszewski JJ 10 19 132 2015 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496313/ 25977310 11 Effectiveness of emergency response planning for sudden cardiac arrest in United States high schools with automated external defibrillators Circulation Drezner JA Rao AL Heistand J Bloomingdale MK Harmon KG 518 525 120 2009 https://pubmed.ncbi.nlm.nih.gov/19635968/ 19635968 12 Incidence of sudden cardiac arrest in high school student athletes on school campus Heart Rhythm Toresdahl BG Rao AL Harmon KG Drezner JA 1190 1194 11 2014 https://pubmed.ncbi.nlm.nih.gov/24732370/ 24732370 13 Sudden cardiac death in the older athlete J Am Coll Cardiol Chugh SS Weiss JB 493 502 65 2015 https://pubmed.ncbi.nlm.nih.gov/25660928/ 25660928 14 Sudden cardiac death during sports activities in the general population Card Electrophysiol Clin Narayanan K Bougouin W Sharifzadehgan A Waldmann V Karam N Marijon E Jouven X 559 567 9 2017 https://pubmed.ncbi.nlm.nih.gov/29173402/ 29173402 15 Incidence of sudden cardiac death in the young: a systematic review BMJ Open Couper K Putt O Field R 0 10 2020 https://pubmed.ncbi.nlm.nih.gov/33033034/ 16 Sudden cardiac death: a nationwide cohort study among the young Dan Med J Risgaard B 63 2016 https://pubmed.ncbi.nlm.nih.gov/27910804/ 17 Incidence and etiology of sudden cardiac death: new updates for athletic departments Sports Health Asif IM Harmon KG 268 279 9 2017 https://pubmed.ncbi.nlm.nih.gov/28452637/ 28452637 18 Vital signs and demographics in the preparticipation sports exam: do they help us find the elusive athlete at risk for sudden cardiac death? Curr Sports Med Rep Sealy DP Pekarek L Russ D Sealy C Goforth G 338 341 9 2010 https://pubmed.ncbi.nlm.nih.gov/21068565/ 21068565 19 Sudden cardiac death in athletes Methodist Debakey Cardiovasc J Wasfy MM Hutter AM Weiner RB 76 80 12 2016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969030/ 27486488 20 Epidemiology of sudden cardiac death and sudden cardiac arrest with resultant disability during high school organized sport in Japan J Sci Med Sport Suzuki-Yamanaka M Ayusawa M Hosokawa Y Hirose N Kaneoka K 705 709 25 2022 https://pubmed.ncbi.nlm.nih.gov/35934658/ 35934658 21 Sudden cardiac death in athletes in Italy during 2019: internet-based epidemiological research Medicina (Kaunas) Sollazzo F Palmieri V Gervasi SF 61 57 2021 https://pubmed.ncbi.nlm.nih.gov/33445447/ 33445447 22 Burden of sudden cardiac death in persons aged 1-40 years in the Czech Republic Cent Eur J Public Health Rücklová K Dobiáš M Bílek M 58 64 30 2022 https://pubmed.ncbi.nlm.nih.gov/35421300/ 35421300 23 Sudden cardiac death among general population and sport related population in forensic experience J Forensic Leg Med Chappex N Schlaepfer J Fellmann F Bhuiyan ZA Wilhelm M Michaud K 62 68 35 2015 https://pubmed.ncbi.nlm.nih.gov/26344462/ 26344462 24 Incidence of sudden cardiac death in athletes: a state-of-the-art review Br J Sports Med Harmon KG Drezner JA Wilson MG Sharma S 1185 1192 48 2014 https://pubmed.ncbi.nlm.nih.gov/24963027/ 24963027 25 Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases Rev Esp Cardiol (Engl Ed) Morentin B Suárez-Mier MP Monzó A Ballesteros J Molina P Lucena J 225 232 74 2021 https://pubmed.ncbi.nlm.nih.gov/32920001/ 32920001 26 Sudden cardiac death in athletes JACC Heart Fail Emery MS Kovacs RJ 30 40 6 2018 https://www.sciencedirect.com/science/article/pii/S2213177917305619?via%3Dihub 29284578 27 Incidence and etiology of sports-related sudden cardiac death in Denmark--implications for preparticipation screening Heart Rhythm Holst AG Winkel BG Theilade J 1365 1371 7 2010 https://pubmed.ncbi.nlm.nih.gov/20580680/ 20580680 28 Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol Corrado D Basso C Rizzoli G Schiavon M Thiene G 1959 1963 42 2003 https://linkinghub.elsevier.com/retrieve/pii/S073510970301194X 14662259 29 Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006 Circulation Maron BJ Doerer JJ Haas TS Tierney DM Mueller FO 1085 1092 119 2009 https://pubmed.ncbi.nlm.nih.gov/19221222/ 19221222 30 Prevention of sudden cardiac death in athletes, sportspersons and marathoners in India Indian Heart J Vora A Burkule N Contractor A Bhargava K 137 145 70 2018 https://www.sciencedirect.com/science/article/pii/S0019483217304388?via%3Dihub 29455769 31 Sudden death in dilated cardiomyopathy Clin Cardiol Wu AH Das SK 267 272 22 1999 https://pubmed.ncbi.nlm.nih.gov/10198736/#:~:text=The%20underlying%20pathophysiology%20of%20sudden,drugs%20and%20devices%20is%20ongoing. 10198736 32 Part 10.1: life-threatening electrolyte abnormalities Circulation 11 2005 American Heart Association 121 125 112 2005 https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.105.166563 33 Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias Circulation Schwartz PJ Priori SG Spazzolini C 89 95 103 2001 https://www.ahajournals.org/doi/full/10.1161/01.CIR.103.1.89 11136691 34 Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas J Am Coll Cardiol Chandra N Bastiaenen R Papadakis M Sharma S 1027 1040 61 2013 https://reader.elsevier.com/reader/sd/pii/S073510971205735X?token=973C9045F1669D4A8DB24F915D0C53E4AF1AB6A26F8F521E7E8B58D94D21CA606570AC1435D01BAB90CCB30B2603A2A3&originRegion=eu-west-1&originCreation=20230518082109 23473408 35 The risk of sudden cardiac death in a patient with non-compaction cardiomyopathy EP Lab Dig Kamalov G 15 2015 https://www.hmpgloballearningnetwork.com/site/eplab/articles/risk-sudden-cardiac-death-patient-non-compaction-cardiomyopathy 36 Aborted sudden death in the Wolff-Parkinson-White syndrome Am J Cardiol Timmermans C Smeets JL Rodriguez LM Vrouchos G van den Dool A Wellens HJ 492 494 76 1995 https://www.sciencedirect.com/science/article/abs/pii/S0002914999801362 7653450 37 Sudden cardiac death and valvular pathology Forensic Sci Res Henriques de Gouveia RH Corte Real Gonçalves FM 280 286 4 2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713097/#:~:text=It%20is%20associated%20to%20aortopathy,1%2C%2013-17%5D. 31489394 38 Out-of-hospital cardiac arrest in a young adult survivor with sequelae of childhood Kawasaki disease: A case report World J Clin Cases Zhu KF Tang LJ Wu SZ Tang YM 3583 3589 7 2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854418/#:~:text=One%20of%20the%20complications%20of,arrest%5B3%2D5%5D. 31750341 39 Stimulant-containing energy drinks ACSMs Health Fit J Higgins JP Babu KM Deuster PA Shearer J 17 21 22 2018 https://www.acc.org/latest-in-cardiology/articles/2018/02/28/10/46/stimulant-containing-energy-drinks 40 Sudden cardiac death in anabolic-androgenic steroid users: a literature review Medicina (Kaunas) Torrisi M Pennisi G Russo I 587 56 2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694262/ 33158202 41 The cardiovascular effects of erythropoietin Cardiovasc Res Smith KJ Bleyer AJ Little WC Sane DC 538 548 59 2003 https://academic.oup.com/cardiovascres/article/59/3/538/344562 14499855 42 Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis Circulation Maison P Chanson P 2648 2652 108 2003 https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000100720.01867.1D 14623813 43 A prospective study of sudden cardiac death among children and young adults N Engl J Med Bagnall RD Weintraub RG Ingles J 2441 2452 374 2016 https://www.nejm.org/doi/full/10.1056/NEJMoa1510687 27332903 44 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease Eur Heart J Pelliccia A Sharma S Gati S 17 96 42 2021 https://academic.oup.com/eurheartj/article/42/1/17/5898937 32860412 45 Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J Corrado D Pelliccia A Bjørnstad HH 516 524 26 2005 https://academic.oup.com/eurheartj/article/26/5/516/2888062 15689345 46 Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: preparticipation screening for cardiovascular disease in competitive athletes: a scientific statement from the American Heart Association and American College of Cardiology Circulation Maron BJ Levine BD Washington RL Baggish AL Kovacs RJ Maron MS 0 72 132 2015 https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000238 47 AMSSM position statement on cardiovascular preparticipation screening in athletes: current evidence, knowledge gaps, recommendations and future directions Clin J Sport Med Drezner JA OʼConnor FG Harmon KG 347 361 26 2016 https://bjsm.bmj.com/content/51/3/153.short 27598018 48 Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance Eur J Clin Invest Mavrogeni SI Bacopoulou F Apostolaki D Chrousos GP 0 48 2018 https://pubmed.ncbi.nlm.nih.gov/29782639/ 49 Avoiding sports-related sudden cardiac death in children with congenital channelopathy : Recommendations for sports activities Herz Lang CN Steinfurt J Odening KE 162 170 42 2017 https://pubmed.ncbi.nlm.nih.gov/28233036/ 28233036 50 Long-QT syndrome and competitive sports Arrhythm Electrophysiol Rev Schnell F Behar N Carré F 187 192 7 2018 https://pubmed.ncbi.nlm.nih.gov/30416732/ 30416732